Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). Eur Urol 2008;53:941-9 and re: John Anderson. Androgen-deprivation therapy--It's all a matter of timing. Eur Urol 2008;53:869-71

Comment

Magdi Mounir Kirollos. Eur Urol. 2009 Feb.

. 2009 Feb;55(2):e40-2; author reply e45-6.

doi: 10.1016/j.eururo.2008.08.039. Epub 2008 Aug 24.

No abstract available

Comment on

Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891).
Studer UE, Collette L, Whelan P, Albrecht W, Casselman J, de Reijke T, Knönagel H, Loidl W, Isorna S, Sundaram SK, Debois M; EORTC Genitourinary Group. Studer UE, et al. Eur Urol. 2008 May;53(5):941-9. doi: 10.1016/j.eururo.2007.12.032. Epub 2007 Dec 27. Eur Urol. 2008. PMID: 18191322 Clinical Trial.
Androgen-deprivation therapy-it's all a matter of timing.
Anderson J. Anderson J. Eur Urol. 2008 May;53(5):869-71. doi: 10.1016/j.eururo.2008.01.044. Epub 2008 Jan 22. Eur Urol. 2008. PMID: 18243500 No abstract available.